BioSpace News Archive

Asana BioSciences, a clinical stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast-Track designation to Asana’s gusacitinib (ASN002), an investigational oral, dual inhibitor of Janus Kinase (JAK) and Spleen Tyrosine Kinase (SYK), for the treatment of moderate-to-severe Chronic Hand Eczema (CHE).

On 18 February, at 08:00 CET, Swedish Orphan Biovitrum AB will publish its report for the forth quarter and full-year 2020.

Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, announced that the company will be presenting at several upcoming conferences in February.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced U.S. Food and Drug Administration (FDA) clearance of the CellFX® System for dermatologic procedures requiring ablation and resurfacing of the skin.

Olympus announced today that it supports the finalized guidance recommendations from the Food and Drug Administration (FDA) indicating that laparoscopic power morcellation in gynecological procedures must be conducted with an approved containment device.

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that it has officially filed for conditional market authorization for CoronaVac, the COVID-19 vaccine, with China’s National Medical Products Administration.

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it will increase production capacity of the company’s SARS-CoV-2 molecular diagnostic test on its Revogene® platform after receiving a $5.5M award from the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative and an additional grant from JobsOhio.

Siemens Healthineers uses the remote connectivity platform TeamViewer to support its imaging and laboratory diagnostic equipment worldwide and keep it operational.

A surgical team from NYU Langone Health performed a face and double hand transplant for a 22-year-old New Jersey resident severely burned in a horrific car crash.

Mr. McKee joined the Board in January of 2021 and brings more than 20 years of biotechnology, life sciences management and venture investment experience to the company.